Changes of cardio- and hemodynamics during treatment of arterial hypertension with adrenergic alpha receptor blockader pyrroxane
Zonis, B.Ia.; Brin, V.B.
Terapevticheskii Arkhiv 51(11): 28-30
1979
ISSN/ISBN: 0040-3660 PMID: 42984 Document Number: 151358
Document emailed within 1 workday
Related Documents
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E. 1981: Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension Polski Tygodnik Lekarski 36(34): 1309-1311Shmidt, I.; Khomut, V.; Monike, V.; Bakh, K.; Fliugel', K. 1985: Central and peripheral hemodynamics during combined treatment of arterial hypertension with calcium antagonist nifedipine and beta-adrenergic blockader talinolol Kardiologiia 25(6): 110-111
Savenkov, P.M.; Doshitsin, V.L.; Grudtsyn, G.V. 1977: Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension Kardiologiia 17(10): 62-66
Leshchinskiĭ, L.A.; Logacheva, I.V.; Nikolaeva, V.A.; Plastinina, R.A.; Polischuk, M.A. 1983: Effect of the combined administration of alpha- and beta-adrenergic blockaders (propranolol and phentolamine) on central and renal hemodynamics during the treatment of patients with arterial hypertension Terapevticheskii Arkhiv 55(9): 48-51
Renouard, A.; Widdowson, P.S.; Millan, M.J. 1994: Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes Journal of Pharmacology and Experimental Therapeutics 270(3): 946-957
Pir'ova, B. 1987: Alpha-adrenergic control of kidney function. its significance for the pathogenesis and treatment of arterial hypertension Vutreshni Bolesti 26(6): 12-18
Price, D.T.; Chari, R.S.; Berkowitz, D.E.; Meyers, W.C.; Schwinn, D.A. 1994: Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification Molecular Pharmacology 46(2): 221-226
Cloix, J.F.; Le Jossec, M.; Baud, O.; Pecquery, R.; Giudicelli, Y.; Dausse, J.P. 1992: Na+/H+ exchangers, alpha-2-adrenergic receptors, sodium sensitivity and arterial hypertension Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 186(4): 377-386
Dominiak, P. 1993: Doxazosin. a postsynaptic alpha 1-adrenergic receptor blocker in therapy of hypertension Der Internist 34(7): 682-687
Eiam-Ong, S.; Eiam-Ong, S.; Punsin, P.; Sitprija, V.; Chaiyabutr, N. 2004: Acute hypercalcemia-induced hypertension: the roles of calcium channel and alpha-1 adrenergic receptor Journal of the Medical Association of Thailand 87(4): 410-418
Zilenovski, A.M.; Freire, C.A.; Iverson, M.T. 1984: Evaluation of the therapeutic efficacy of a fixed combination of beta blockader and diuretic, in the treatment of systemic arterial hypertension. a multicenter study Arquivos Brasileiros de Cardiologia 42(6): 435-441
De Gregorio, G.; De Gregorio, C. 1988: Treatment of arterial hypertension for cardio-cerebral protection: role of calcium antagonists La Clinica Terapeutica 127(5): 335-341
Riabova, K.G.; Pashkova, T.L.; Bichev, A.A. 1988: Effect of the alpha-adrenergic blockader prazosin on physical effort-induced bronchospasm in bronchial asthma Sovetskaia Meditsina 8: 58-61
Takenaka, F.; Ishihara, T.; Maruyama, Y.; Matsumoto, S.; Inoue, H. 1974: Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(3): 385-397
De Petra, V.; Di Michele, R.; Cecchetti, E. 1973: Effects of an adrenergic beta receptor blockader on exercise tolerance and myocardial function in patients with angina pectoris Minerva Cardioangiologica 21(9): 619-624
Bylund, D.B.; Ray-Prenger, C. 1989: Alpha-2A and alpha-2B adrenergic receptor subtypes: attenuation of cyclic AMP production in cell lines containing only one receptor subtype Journal of Pharmacology and Experimental Therapeutics 251(2): 640-644
Schmidt, E.; Bruch H-P 1978: 1st experiences with the alpha-receptor blockader phentolamine in achalasia Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 49(1): 22-24
Lorenz, W.; Lomasney, J.W.; Collins, S.; Regan, J.W.; Caron, M.G.; Lefkowitz, R.J. 1990: Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification Molecular Pharmacology 38(5): 599-603
Price, D.T.; Lefkowitz, R.J.; Caron, M.G.; Berkowitz, D.; Schwinn, D.A. 1994: Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology Molecular Pharmacology 45(2): 171-175
Spasov, A.A.; Gurbanov, K.G.; Seredintseva, N.V.; Paperno, A.A. 1997: The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension Eksperimental'naia i Klinicheskaia Farmakologiia 60(3): 30-33